Clinical Trial Update: Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring treatment strategies and survival outcomes for non-small cell lung cancer with oncogenic mutations; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Non Small Cell Lung Cancer, EGFR Gene Mutation | Phase 2 | Status: RECRUITING